Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort study
Xianchun Gao(National Clinical Research Center for Digestive Diseases), Yongzhan Nie(Xijing Hospital), Zhenning Wang(First Hospital of China Medical University), Linbin Lu(National Clinical Research Center for Digestive Diseases), Peng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Shang, Yingtai Chen(Shanghai Jiao Tong University), Rupeng Zhang(Second Affiliated Hospital of Xi'an Jiaotong University), Kaichun Wu(Xijing Hospital), Ping Fan(Sichuan University), Huanqiu Chen(Jiangsu Cancer Hospital), Lulu Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Li(Shanxi University), Yu Fu(Hangzhou Medical College), Shaoqi Yang(Ningxia Medical University), Han Liang(Sun Yat-sen University), Jun Yu(Yueyang Second People's Hospital), Nannan Zhang(Lanzhou University), Fang He(Second Affiliated Hospital of Zhejiang University), Shibo Wang(National Clinical Research Center for Digestive Diseases), Gan Zhang(Nanchang University), Wanqing Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Ji(Centre National de la Recherche Scientifique), Weili Han(National Clinical Research Center for Digestive Diseases), Yunhe Gao(Chinese Academy of Sciences), Qingchuan Zhao(City University of Hong Kong), Hongqing Xi(Chinese PLA General Hospital), Jingyu Deng(Tianjin Medical University Cancer Institute and Hospital), Zhiyi Zhang(Jiangnan University), Rui Peng(Guangzhou University of Chinese Medicine), Cen Si(Ningxia Medical University), Junya Yan(National Clinical Research Center for Digestive Diseases), Junguo Hu(Huawei Technologies (China))
Cited by 9
Related Papers
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480